This week's Fierce Pharma is brought to you by Stevanato Group.

Solving the Silicone Challenge in Pre-Fillable Syringes

The global rise of biologics and biosimilars is reshaping drug development—and with it, the expectations for drug delivery systems. As the market accelerates past the $300 billion threshold, injectable therapies are increasingly self-administered, more concentrated, and delivered in higher volumes. This new reality brings both opportunity and complexity. Access our valuable whitepaper today to gain the insights you need to stay competitive and compliant. You'll learn about:

• How rising drug viscosities and volumes are challenging standard delivery systems
• Why early container–device–formulation compatibility testing is critical
• Strategies to minimize stability testing issues and reduce time-to-market risk
• Key trends in patient-centric delivery and what they mean for product design
• How delivery considerations impact everything from regulatory planning to user experience
• And more

Want even more content from Fierce Pharma on integrated strategies for safe and effective drug delivery? Visit our exclusive resource center today!